SEC Form 4 · accession 0001209191-15-072339

ALDER BIOPHARMACEUTICALS INC · ALDR

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chief Business Officer

Period of report

Sep 24, 2015

Accepted (ET)

Sep 28, 2015 · 6:11 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001423824

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock	Sep 24, 2015	M	12,764	$1.265	A	80,419	D
Common Stock	holding	—	—		—	30,000	I	Held in trust for the benefit of Reporting Person's minor child
Common Stock	holding	—	—		—	30,000	I	Held in trust for the benefit of Reporting Person's minor child
Common Stock	holding	—	—		—	30,000	I	Held in trust for the benefit of Reporting Person's minor child

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (Right to Buy)^F1	$1.265	Sep 24, 2015	M	12,764	D	—	Nov 13, 2017	Common Stock	12,764	7,690	D